Do generic health instruments comprehensively capture patient perceived improvement in patients with carpal tunnel syndrome?
These results suggest that standard tools may not be sufficiently sensitive to show clinically significant change in this common rheumatological problem.
Long-term losartan- vs atenolol-based antihypertensive treatment did not influence collagen markers differently, making a BP-independent effect of losartan on collagen markers unlikely. However, initial reduction in circulating PICP may predict later regression of LV hypertrophy during losartan-based antihypertensive treatment.